Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature

HIGHLIGHTS

• who: Jessica A. Scarborough from the Published in partnership with The Hormel Institute, University of Minnesota have published the article: Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature, in the Journal: (JOURNAL) of 25/02/2020
• what: And finally, the authors provide an example of how CisSig may be translated for use in a single disease site, muscle-invasive bladder cancer (MIBC), predicting which patients will benefit less from cisplatincontaining chemotherapy. In Supplementary Fig 4, the authors show a heatmap of mutation status for 16 genes across all epithelialbased cell . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.